Home/Filings/4/0001181431-13-015378
4//SEC Filing

Hamill John 4

Accession 0001181431-13-015378

CIK 0000722104other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:49 PM ET

Size

5.8 KB

Accession

0001181431-13-015378

Insider Transaction Report

Form 4
Period: 2013-03-05
Hamill John
SVP, CFO
Transactions
  • Award

    Option to Purchase Common Stock

    2013-03-05+110,000110,000 total
    Exercise: $0.94Exp: 2023-03-05Common Stock (110,000 underlying)
Holdings
  • Common Stock

    103,613
Footnotes (1)
  • [F1]These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013.

Issuer

SAVIENT PHARMACEUTICALS INC

CIK 0000722104

Entity typeother

Related Parties

1
  • filerCIK 0001559058

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:49 PM ET
Size
5.8 KB